SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike RBD Recombinant Protein

Product Specifications

Background

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full Receptor-Binding Domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.351, also commonly known as the "SA / South Africa mutant".

CAS Number

9000-83-3

NCBI Gene ID

43740568

Swiss Prot

P0DTC2

Tag

C-terminal His tag

Type

Recombinant Proteins

Source

HEK293 cells

Field of Research

Infectious Disease, COVID-19

Concentration

Batch dependent

Purity

>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.

Buffer

20 mM Hepes pH 7.5; 150 mM NaCl

Shipping Conditions

Dry Ice

Storage Conditions

–80˚ C. Avoid freeze-thaw cycles

Calculated Molecular Weight

225 amino acids (including His tag) ; 25506 Da

Applications Notes

This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.

NCBI Official Name

Surface glycoprotein

NCBI Organism

Severe acute respiratory syndrome coronavirus 2

Other Product Names

SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein